| 000 | 01761 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516080605.0 | ||
| 264 | 0 | _c20121207 | |
| 008 | 201212s 0 0 eng d | ||
| 022 | _a1478-3231 | ||
| 024 | 7 |
_a10.1111/j.1478-3231.2012.02770.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStravitz, R Todd | |
| 245 | 0 | 0 |
_aSubstitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation. _h[electronic resource] |
| 260 |
_bLiver international : official journal of the International Association for the Study of the Liver _cAug 2012 |
||
| 300 |
_a1138-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xeconomics |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aEmtricitabine |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins _xeconomics |
| 650 | 0 | 4 | _aLiver Transplantation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganophosphonates _xeconomics |
| 650 | 0 | 4 | _aSecondary Prevention |
| 650 | 0 | 4 | _aTenofovir |
| 700 | 1 | _aShiffman, Mitchell L | |
| 700 | 1 | _aKimmel, Melissa | |
| 700 | 1 | _aPuri, Puneet | |
| 700 | 1 | _aLuketic, Velimir A | |
| 700 | 1 | _aSterling, Richard K | |
| 700 | 1 | _aSanyal, Arun J | |
| 700 | 1 | _aCotterell, Adrian H | |
| 700 | 1 | _aPosner, Marc P | |
| 700 | 1 | _aFisher, Robert A | |
| 773 | 0 |
_tLiver international : official journal of the International Association for the Study of the Liver _gvol. 32 _gno. 7 _gp. 1138-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1478-3231.2012.02770.x _zAvailable from publisher's website |
| 999 |
_c21558609 _d21558609 |
||